Can gut bacteria predict bladder cancer treatment success?
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how the bacteria living in your gut and bladder (your microbiome) might affect the course of non-muscle invasive bladder cancer (NMIBC). By collecting tissue samples, researchers hope to learn if certain bacteria can help predict how the disease will progress or respond to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and can give consent.
- You have been diagnosed with non-muscle invasive bladder cancer (NMIBC).
- You do not have a current urinary tract infection.
- You have not taken antibiotics in the last month.
- You have not had chemotherapy or immunotherapy in the last 3 months.
- You do not have uncontrolled diabetes, another active cancer, or an autoimmune disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the bacteria in your gut and bladder to understand how they may relate to bladder cancer. It is for men who are having their first tumor removal for suspected bladder cancer, and helps researchers learn if the microbiome plays a role.
This study looks at bacteria in urine and the bladder to understand if they play a role in causing bladder cancer. Researchers will compare samples from men with bladder cancer and healthy controls.
This study compares the bacteria in urine of men with bladder cancer to those with other urinary issues and healthy men. For bladder cancer patients, it looks at differences before a planned surgery to remove the bladder.
This study examines whether a simple blood test can detect cancer DNA (circulating tumor DNA, or ctDNA) in patients with a specific type of bladder cancer. Detecting this DNA in blood may help doctors predict how the cancer will behave and guide future treatment decisions.
This study looks at how fluid absorbed during bladder cancer removal surgery affects cell-free DNA (tiny pieces of cancer DNA) in your blood. Researchers want to understand if these blood markers can help predict surgery outcomes and guide treatment decisions.
This trial tests a combination of probiotics, targeted therapy, and immunotherapy aimed at preserving the bladder in people with muscle-invasive bladder cancer. It's for those who can't have standard surgery or cisplatin chemo, and whose tumors have a certain protein (HER2).
Hear when a new Urinary Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.